ReviewCritical reviews in oncology/hematology2025

Targeting cancer metabolism: Therapeutic potential of the fatty acid synthase (FASN) inhibitors.

Pier Vitale Nuzzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.